Malignant Trophoblastic Neoplasia
- 12 January 1972
- journal article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 51 (3) , 275-281
- https://doi.org/10.3109/00016347209156858
Abstract
Malignant trophoblastic neoplasia is uncommon in Scandinavia, only 4–5 cases per 100 000 live births being reported to the National Cancer Registries each year. In a small series comprising 30 patients the effectiveness of chemotherapy in curing non‐metastatic as well as metastatic disease was confirmed. Of 16 women with metastatic choriocarcinoma, 12 were cured by combined treatment with methotrexate and actinomycin D. In the monitoring of treatment and follow‐up of the patients radioimmunoassay of LH in serum was found more sensitive and reliable than determination of HCG in 24‐hour urine. A delayed response to chemotherapy with fluctuating hormone levels during chemotherapy was observed to be of prognostic and therapeutic significance.This publication has 7 references indexed in Scilit:
- Hydatidiform Mole, Invasive Mole and Choriocarcinoma in Sweden 1958–1965Acta Obstetricia et Gynecologica Scandinavica, 1970
- Pelvic arteriography in malignant trophoblastic neoplasiaAmerican Journal of Obstetrics and Gynecology, 1969
- Chemotherapy and Surgery in the Treatment of Gestational Trophoblastic NeoplasmsSurgical Clinics of North America, 1969
- ChoriocarcinomaPublished by Springer Nature ,1967
- Sequential use of methotrexate and actinomycin D in the treatment of metastatic choriocarcinoma and related trophoblastic diseases in womenAmerican Journal of Obstetrics and Gynecology, 1965
- Chemotherapy in trophoblastic diseasesAmerican Journal of Obstetrics and Gynecology, 1964
- Effect of Methotrexate Therapy upon Choriocarcinoma and ChorioadenomaExperimental Biology and Medicine, 1956